- Home
- BLCO vs RYAN Comparison
BLCO vs RYAN Comparison
Compare BLCO & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLCO | RYAN |
|---|---|---|
| Founded | 1853 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.1B |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BLCO | RYAN |
|---|---|---|
| Price | $16.85 | $37.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | $18.55 | ★ $56.00 |
| AVG Volume (30 Days) | 429.4K | ★ 2.7M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | $3,051,126,000.00 |
| Revenue This Year | $8.61 | $18.15 |
| Revenue Next Year | $5.52 | $13.74 |
| P/E Ratio | ★ N/A | $86.72 |
| Revenue Growth | 6.47 | ★ 21.28 |
| 52 Week Low | $10.45 | $35.85 |
| 52 Week High | $18.92 | $77.00 |
Technical Indicators
Market Signals| Indicator | BLCO | RYAN |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 34.46 |
| Support Level | $16.35 | N/A |
| Resistance Level | $16.81 | $40.44 |
| Average True Range (ATR) | 0.51 | 1.51 |
| MACD | -0.16 | 0.07 |
| Stochastic Oscillator | 1.24 | 24.79 |
Price Performance
Historical ComparisonAbout BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.